Home/Editorial Board

Editorial Board

Journal of ImmunoTherapy of Cancer Editorial Board members have agreed and adhere to the BMJ Editor Roles and Responsibilities guidelines; including our Editor policy on competing interests.

Interim Editor-in-Chief

James L. Gulley, MD, PhD, FACP National Cancer Institute, National Institutes of Health, United States Declaration of Interests, see here

Incoming Editor-in-Chief

Michael T. Lotze, MD University of Pittsburgh, United States Declaration of Interests

Deputy Editor-in-Chief

Sjoerd H. van der Burg, PhD Oncode Institute & Leiden University Medical Center, Netherlands Declaration of Interests

Basic Tumor Immunology

Section Editor
Claudia Palena, PhD National Cancer Institute, National Institutes of Health, United States
Eric Tartour, MD, PhD Hôpital Européen Georges Pompidou, France
Associate Editors
Scott I. Abrams, PhD Roswell Park Comprehensive Cancer Center, United States Timothy NJ Bullock, PhD* University of Virginia, United States ORCID logo orcid.org/0000-0001-6141-3261 Gennaro Ciliberto, MD IRCCS Istituto Nazionale Tumori Regina Elena, Italy ORCID logo orcid.org/0000-0003-2851-8605 Khashayarsha Khazaie, PhD, DSc Mayo Clinic College of Medicine, United States
Michael Platten, MD Ruprecht-Karls University Heidelberg, Germany ORCID logo orcid.org/0000-0002-4746-887X Stefani Spranger, PhD Massachusetts Institute of Technology, United States Walter J. Storkus, PhD University of Pittsburgh, United States Viktor Umansky, PhD German Cancer Research Center (DKFZ), Germany

Case Reports

Section Editor
Sebastian Kobold, MD Klinikum der Universität München, Germany
Associate Editors
Jack D. Bui, MD, PhD University of California San Diego, United States ORCID logo orcid.org/0000-0002-9324-368X Marco Donia, MD, PhD National Center for Cancer Immune Therapy, Denmark ORCID logo orcid.org/0000-0003-4966-9752
Heinz Läubli, MD, PhD University Hospital Basel, Switzerland orcid.org/0000-0002-8910-5620 Allison Betof Warner, MD, PhD Stanford Cancer Center, United States

Clinical/Translational Cancer Immunotherapy

Section Editors
Jason J. Luke, MD, FACP University of Pittsburgh Medical Center, United States ORCID logo orcid.org/0000-0002-1182-4908
Douglas G. McNeel, MD, PhD University of Wisconsin Carbone Cancer Center, United States ORCID logo orcid.org/0000-0003-1471-6723
Associate Editors
Paolo Antonio Ascierto, MD Istituto Nazional Tumori-Fondazione ‘G.Pascale’, Italy ORCID logo orcid.org/0000-0002-8322-475X Richard D. Carvajal, MD Northwell Health Cancer Institute, United States Tina Cascone, MD, PhD The University of Texas MD Anderson Cancer Center, United States Tanja D. de Gruijl, PhD Amsterdam University Medical Centers, the Netherlands ORCID logo orcid.org/0000-0003-1464-8978 Brian R. Gastman, MD Iovance Biotherapeutics, Inc., United States Margaret E. Gatti-Mays, MD, MPH Ohio State University Comprehensive Cancer Center, United States ORCID logo orcid.org/0000-0001-8914-2897 Francois Ghiringhelli, PhD  Institut National De La Sante Et De Le Recherche Medicale (INSERM), France James J. Harding, MD Memorial Sloan Kettering Cancer Center, United States Hongbo Hu, PhD West China Hospital, Sichuan University, China Douglas B. Johnson, MD, MSCI* Vanderbilt University Medical Center, United States Pawel Kalinski, MD, PhD* Roswell Park Comprehensive Cancer Center, United States
Yangqiu Li, MD Jinan University School of Medicine, China Ravi A. Madan, MD National Cancer Institute, National Institutes of Health, United States ORCID logo orcid.org/0000-0001-5106-8636 Luca Mazzarella, MD, PhD European Institute of Oncology, Italy ORCID logo orcid.org/0000-0002-4043-3279 Sattva S. Neelapu, MD The University of Texas MD Anderson Cancer Center, United States Anna Obenauf, PhD Research Institute of Molecular Pathology, Austria Kunle Odunsi, MD, PhD University of Chicago Medicine Comprehensive Cancer Center, United States Ravi Patel, MD, PhD University of Pittsburgh, United States ORCID logo orcid.org/0000-0002-8328-746X Alessandro Russo, MD, PhD Università degli Studi di Messina, Italy Louis M. Weiner, MD Georgetown-Lombardi Comprehensive Cancer Center, United States ORCID logo orcid.org/0000-0001-5192-0710

Commentary/Editorials

Section Editor
Christian M. Capitini, MD University of Wisconsin, Madison, United States ORCID logo orcid.org/0000-0002-2276-6731
Associate Editors
Ana Carrizosa Anderson, MD Harvard University, United States ORCID logo orcid.org/0000-0002-0877-2932 William J. Murphy, PhD University of California, Davis, United States ORCID logo orcid.org/0000-0002-2793-401X Gabriel Rabinovich, PhD Instituto de Biologia y Medicina Experimental (IByME), Argentina ORCID logo orcid.org/0000-0002-0947-8735

Guidelines and Consensus Statements

Section Editor
Robert L. Ferris, MD, PhD University of Pittsburgh Cancer Institute, United States ORCID logo orcid.org/0000-0001-6605-2071

Immune Cell Therapies and Immune Cell Engineering

Section Editor
Marcela V. Maus, MD, PhD Massachusetts General Hospital, United States
Deputy Editor
Aude Chapuis, MD Fred Hutchinson Cancer Research Center, United States
Associate Editors
Marco L. Davila, MD, PhD* Roswell Park Comprehensive Cancer Center, United States ORCID logo orcid.org/0000-0002-6270-3065 Joseph A. Fraietta, PhD University of Pennsylvania, United States ORCID logo orcid.org/0000-0001-7900-8993 Sara Ghorashian, MD, PhD University College London, United Kingdom ORCID logo orcid.org/0000-0002-1555-2946 Jennifer L. Guerriero, PhD Brigham and Women’s Hospital, United States ORCID logo orcid.org/0000-0002-2104-5457 Michael Hudecek, MD Universitätsklinikum Würzburg, Germany Gerald Linette, MD, PhD University of Pennsylvania, United States ORCID logo orcid.org/0000-0001-6147-6115 Daniel J. Powell, Jr., PhD University of Pennsylvania, United States ORCID logo orcid.org/0000-0002-5966-8908
Marco Ruella, MD University of Pennsylvania, United States ORCID logo orcid.org/0000-0003-4301-5811 Lillian Seu, PhD Revolution Medicines, United States ORCID logo orcid.org/0000-0002-8456-019X Nirali N. Shah, MD, MHSc National Cancer Institute, National Institutes of Health, United States ORCID logo orcid.org/0000-0002-8474-9080 Eric L. Smith, MD, PhD Dana-Farber Cancer Institute, United States ORCID logo orcid.org/0000-0002-0296-7587 Maria Themeli, MD, PhD VUmc Cancer Center Amsterdam, the Netherlands

Immunotherapy Biomarkers

Section Editor
Ignacio Melero, MD, PhD University of Navarra, Spain ORCID logo orcid.org/0000-0002-1360-348X
Alexandra Snyder Charen, MD Generate Biomedicines, United States ORCID logo orcid.org/0000-0002-2606-3523
Deputy Editor
Kurt Schalper, MD, PhD Yale School of Medicine, United States
Associate Editors
Valsamo Anagnostou, MD, PhD Johns Hopkins University, United States Maria Ascierto, PhD AstraZeneca, United States Carlo B. Bifulco, MD Providence Portland Medical Center, United States John C. Castle, PhD Monte Rosa Therapeutics, Switzerland ORCID logo orcid.org/0000-0001-8697-8955 Alessandra Cesano, MD, PhD* ESSA Pharma Inc., United States Eric Deutsch, MD, PhD Gustave Roussy Cancer Campus, France Jolanda de Vries, PhD Radboud University Nijmegen, the Netherlands Elisabeth G.E. de Vries, MD, PhD University Medical Centre Groningen, the Netherlands Michael D. Kalos, PhD* CTRL Therapeutics, United States Rejean Lapointe, PhD Universite De Montreal, University Hospital (CRCHUM), Canada
Christian H. Ottensmeier, MD, PhD, FRCP University of Liverpool, United Kingdom Graham P. Pawelec, PhD University of Tuebingen, Germany ORCID logo orcid.org/0000-0002-3600-0163 Licia Rivoltini, MD Fondazione IRCCS Istituto Nazionale Tumori, Italy Barbara Seliger, MD, PhD Martin Luther University Halle-Wittenberg, Germany ORCID logo orcid.org/0000-0002-5544-4958 Craig L. Slingluff Jr., MD University of Virginia, United States ORCID logo orcid.org/0000-0002-6664-4373 Claudio Tripodo, MD University of Palermo, Italy ORCID logo orcid.org/0000-0002-0821-6231 Jianda Yuan, MD, PhD Merck & Co., United States ORCID logo orcid.org/0000-0003-3551-4434

Oncolytic and Local Immunotherapy

Section Editor
Howard L. Kaufman, MD, FACS Massachusetts General Hospital, United States ORCID logo orcid.org/0000-0003-1131-004X
Associate Editors
John C. Bell, PhD Ottawa Hospital Research Institute, Canada ORCID logo orcid.org/0000-0002-9083-357X Kevin Harrington, PhD, FRCP, FRCR The Institute of Cancer Research, United Kingdom ORCID logo orcid.org/0000-0002-6014-348X Samuel Rabkin, PhD* Massachusetts General Hospital, United States ORCID logo orcid.org/0000-0003-2344-2795
K. Dane Wittrup, PhD Massachusetts Institute of Technology, United States Dmitriy Zamarin, MD, PhD Icahn School of Medicine at Mount Sinai, United States ORCID logo orcid.org/0000-0002-0094-0161

Reviews

Section Editors
Sandra Demaria, MD Weill Cornell Medical College, United States ORCID logo orcid.org/0000-0003-4426-0499
Lawrence Fong, MD University of California, San Francisco, United States
Associate Editors
Michael B. Atkins, MD Georgetown-Lombardi Comprehensive Cancer Center, United States ORCID logo orcid.org/0000-0003-3901-9924 Ira Mellman, PhD Genentech, United States ORCID logo orcid.org/0000-0002-6132-7299 James J. Mule, PhD H. Lee Moffitt Cancer Center & Research Institute, United States ORCID logo orcid.org/0000-0001-7354-0516

Specialty Editors

Consulting Editor, Special Series and Reviews
Pedro J. Romero, MD† Novigenix, Switzerland
Consulting Editor
Thomas F. Gajewski, MD, PhD University of Chicago, United States
Social Media Editors
Kristin G. Anderson, PhD University of Virginia, United States Praveen Bommareddy, PhD, MS Replimune, Inc., United States Cheng Sun, MD, PhD University of Science and Technology of China, China
   
†Founding Editor-in-Chief (2013-2023) *Consulting Reviews Editor

Publishing Team

Publisher: Shannon Lewis Head of Portfolio: Kathleen Lyons